The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Mydriatic Eyedrops-Global Market Insights and Sales Trends 2025

Mydriatic Eyedrops-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1818448

No of Pages : 118

Ask Your Query
Synopsis
The global Mydriatic Eyedrops market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Mydriatic Eyedrops in various end use industries. The expanding demands from the Adult and Children, are propelling Mydriatic Eyedrops market. Atropine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Homatropine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Mydriatic Eyedrops, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Mydriatic Eyedrops market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Mydriatic Eyedrops market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Mydriatic Eyedrops sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Mydriatic Eyedrops covered in this report include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, etc.
The global Mydriatic Eyedrops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Global Mydriatic Eyedrops market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mydriatic Eyedrops market, Segment by Type:
Atropine
Homatropine
Dolly
Others
Global Mydriatic Eyedrops market, by Application
Adult
Children
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Mydriatic Eyedrops manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Mydriatic Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Mydriatic Eyedrops Market Overview
1.1 Mydriatic Eyedrops Product Overview
1.2 Mydriatic Eyedrops Market Segment by Type
1.2.1 Atropine
1.2.2 Homatropine
1.2.3 Dolly
1.2.4 Others
1.3 Global Mydriatic Eyedrops Market Size by Type
1.3.1 Global Mydriatic Eyedrops Market Size Overview by Type (2018-2029)
1.3.2 Global Mydriatic Eyedrops Historic Market Size Review by Type (2018-2023)
1.3.3 Global Mydriatic Eyedrops Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Mydriatic Eyedrops Sales Breakdown by Type (2018-2023)
1.4.2 Europe Mydriatic Eyedrops Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Mydriatic Eyedrops Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Mydriatic Eyedrops Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Mydriatic Eyedrops Sales Breakdown by Type (2018-2023)
2 Global Mydriatic Eyedrops Market Competition by Company
2.1 Global Top Players by Mydriatic Eyedrops Sales (2018-2023)
2.2 Global Top Players by Mydriatic Eyedrops Revenue (2018-2023)
2.3 Global Top Players by Mydriatic Eyedrops Price (2018-2023)
2.4 Global Top Manufacturers Mydriatic Eyedrops Manufacturing Base Distribution, Sales Area, Product Type
2.5 Mydriatic Eyedrops Market Competitive Situation and Trends
2.5.1 Mydriatic Eyedrops Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Mydriatic Eyedrops Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Mydriatic Eyedrops as of 2022)
2.7 Date of Key Manufacturers Enter into Mydriatic Eyedrops Market
2.8 Key Manufacturers Mydriatic Eyedrops Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Mydriatic Eyedrops Status and Outlook by Region
3.1 Global Mydriatic Eyedrops Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Mydriatic Eyedrops Historic Market Size by Region
3.2.1 Global Mydriatic Eyedrops Sales in Volume by Region (2018-2023)
3.2.2 Global Mydriatic Eyedrops Sales in Value by Region (2018-2023)
3.2.3 Global Mydriatic Eyedrops Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Mydriatic Eyedrops Forecasted Market Size by Region
3.3.1 Global Mydriatic Eyedrops Sales in Volume by Region (2024-2029)
3.3.2 Global Mydriatic Eyedrops Sales in Value by Region (2024-2029)
3.3.3 Global Mydriatic Eyedrops Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Mydriatic Eyedrops by Application
4.1 Mydriatic Eyedrops Market Segment by Application
4.1.1 Adult
4.1.2 Children
4.2 Global Mydriatic Eyedrops Market Size by Application
4.2.1 Global Mydriatic Eyedrops Market Size Overview by Application (2018-2029)
4.2.2 Global Mydriatic Eyedrops Historic Market Size Review by Application (2018-2023)
4.2.3 Global Mydriatic Eyedrops Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Mydriatic Eyedrops Sales Breakdown by Application (2018-2023)
4.3.2 Europe Mydriatic Eyedrops Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Mydriatic Eyedrops Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Mydriatic Eyedrops Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Mydriatic Eyedrops Sales Breakdown by Application (2018-2023)
5 North America Mydriatic Eyedrops by Country
5.1 North America Mydriatic Eyedrops Historic Market Size by Country
5.1.1 North America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Mydriatic Eyedrops Sales in Volume by Country (2018-2023)
5.1.3 North America Mydriatic Eyedrops Sales in Value by Country (2018-2023)
5.2 North America Mydriatic Eyedrops Forecasted Market Size by Country
5.2.1 North America Mydriatic Eyedrops Sales in Volume by Country (2024-2029)
5.2.2 North America Mydriatic Eyedrops Sales in Value by Country (2024-2029)
6 Europe Mydriatic Eyedrops by Country
6.1 Europe Mydriatic Eyedrops Historic Market Size by Country
6.1.1 Europe Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Mydriatic Eyedrops Sales in Volume by Country (2018-2023)
6.1.3 Europe Mydriatic Eyedrops Sales in Value by Country (2018-2023)
6.2 Europe Mydriatic Eyedrops Forecasted Market Size by Country
6.2.1 Europe Mydriatic Eyedrops Sales in Volume by Country (2024-2029)
6.2.2 Europe Mydriatic Eyedrops Sales in Value by Country (2024-2029)
7 Asia-Pacific Mydriatic Eyedrops by Region
7.1 Asia-Pacific Mydriatic Eyedrops Historic Market Size by Region
7.1.1 Asia-Pacific Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Mydriatic Eyedrops Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Mydriatic Eyedrops Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Mydriatic Eyedrops Forecasted Market Size by Region
7.2.1 Asia-Pacific Mydriatic Eyedrops Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Mydriatic Eyedrops Sales in Value by Region (2024-2029)
8 Latin America Mydriatic Eyedrops by Country
8.1 Latin America Mydriatic Eyedrops Historic Market Size by Country
8.1.1 Latin America Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Mydriatic Eyedrops Sales in Volume by Country (2018-2023)
8.1.3 Latin America Mydriatic Eyedrops Sales in Value by Country (2018-2023)
8.2 Latin America Mydriatic Eyedrops Forecasted Market Size by Country
8.2.1 Latin America Mydriatic Eyedrops Sales in Volume by Country (2024-2029)
8.2.2 Latin America Mydriatic Eyedrops Sales in Value by Country (2024-2029)
9 Middle East and Africa Mydriatic Eyedrops by Country
9.1 Middle East and Africa Mydriatic Eyedrops Historic Market Size by Country
9.1.1 Middle East and Africa Mydriatic Eyedrops Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Mydriatic Eyedrops Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Mydriatic Eyedrops Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Mydriatic Eyedrops Forecasted Market Size by Country
9.2.1 Middle East and Africa Mydriatic Eyedrops Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Mydriatic Eyedrops Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis AG
10.1.1 Novartis AG Company Information
10.1.2 Novartis AG Introduction and Business Overview
10.1.3 Novartis AG Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis AG Mydriatic Eyedrops Products Offered
10.1.5 Novartis AG Recent Development
10.2 Allergan, Inc.
10.2.1 Allergan, Inc. Company Information
10.2.2 Allergan, Inc. Introduction and Business Overview
10.2.3 Allergan, Inc. Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Allergan, Inc. Mydriatic Eyedrops Products Offered
10.2.5 Allergan, Inc. Recent Development
10.3 Meda Pharmaceuticals Inc
10.3.1 Meda Pharmaceuticals Inc Company Information
10.3.2 Meda Pharmaceuticals Inc Introduction and Business Overview
10.3.3 Meda Pharmaceuticals Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Meda Pharmaceuticals Inc Mydriatic Eyedrops Products Offered
10.3.5 Meda Pharmaceuticals Inc Recent Development
10.4 Bausch & Lomb Inc
10.4.1 Bausch & Lomb Inc Company Information
10.4.2 Bausch & Lomb Inc Introduction and Business Overview
10.4.3 Bausch & Lomb Inc Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Bausch & Lomb Inc Mydriatic Eyedrops Products Offered
10.4.5 Bausch & Lomb Inc Recent Development
10.5 Cigna
10.5.1 Cigna Company Information
10.5.2 Cigna Introduction and Business Overview
10.5.3 Cigna Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Cigna Mydriatic Eyedrops Products Offered
10.5.5 Cigna Recent Development
10.6 Similasan Corporation
10.6.1 Similasan Corporation Company Information
10.6.2 Similasan Corporation Introduction and Business Overview
10.6.3 Similasan Corporation Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Similasan Corporation Mydriatic Eyedrops Products Offered
10.6.5 Similasan Corporation Recent Development
10.7 Visine
10.7.1 Visine Company Information
10.7.2 Visine Introduction and Business Overview
10.7.3 Visine Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Visine Mydriatic Eyedrops Products Offered
10.7.5 Visine Recent Development
10.8 Alcon
10.8.1 Alcon Company Information
10.8.2 Alcon Introduction and Business Overview
10.8.3 Alcon Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Alcon Mydriatic Eyedrops Products Offered
10.8.5 Alcon Recent Development
10.9 Viva Opti-Free
10.9.1 Viva Opti-Free Company Information
10.9.2 Viva Opti-Free Introduction and Business Overview
10.9.3 Viva Opti-Free Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Viva Opti-Free Mydriatic Eyedrops Products Offered
10.9.5 Viva Opti-Free Recent Development
10.10 Bausch & Lomb
10.10.1 Bausch & Lomb Company Information
10.10.2 Bausch & Lomb Introduction and Business Overview
10.10.3 Bausch & Lomb Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Bausch & Lomb Mydriatic Eyedrops Products Offered
10.10.5 Bausch & Lomb Recent Development
10.11 Systane
10.11.1 Systane Company Information
10.11.2 Systane Introduction and Business Overview
10.11.3 Systane Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Systane Mydriatic Eyedrops Products Offered
10.11.5 Systane Recent Development
10.12 Rite Aid
10.12.1 Rite Aid Company Information
10.12.2 Rite Aid Introduction and Business Overview
10.12.3 Rite Aid Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Rite Aid Mydriatic Eyedrops Products Offered
10.12.5 Rite Aid Recent Development
10.13 Walgreens
10.13.1 Walgreens Company Information
10.13.2 Walgreens Introduction and Business Overview
10.13.3 Walgreens Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Walgreens Mydriatic Eyedrops Products Offered
10.13.5 Walgreens Recent Development
10.14 Staples
10.14.1 Staples Company Information
10.14.2 Staples Introduction and Business Overview
10.14.3 Staples Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Staples Mydriatic Eyedrops Products Offered
10.14.5 Staples Recent Development
10.15 Clear eyes
10.15.1 Clear eyes Company Information
10.15.2 Clear eyes Introduction and Business Overview
10.15.3 Clear eyes Mydriatic Eyedrops Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Clear eyes Mydriatic Eyedrops Products Offered
10.15.5 Clear eyes Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Mydriatic Eyedrops Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Mydriatic Eyedrops Industrial Chain Analysis
11.4 Mydriatic Eyedrops Market Dynamics
11.4.1 Mydriatic Eyedrops Industry Trends
11.4.2 Mydriatic Eyedrops Market Drivers
11.4.3 Mydriatic Eyedrops Market Challenges
11.4.4 Mydriatic Eyedrops Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Mydriatic Eyedrops Distributors
12.3 Mydriatic Eyedrops Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock